Pro Medicus Limited (ASX: PME)
136.39
+0.30 (0.22%)
Jul 3, 2024, 4:10 PM AEST
Pro Medicus Revenue
Pro Medicus had revenue of 142.12M AUD in the twelve months ending December 31, 2023, with 76.27% growth year-over-year. Revenue in the quarter ending December 31, 2023 was 74.11M AUD with 67.18% year-over-year growth. In the fiscal year ending June 30, 2023, Pro Medicus had annual revenue of 124.90M AUD with 33.64% growth.
Revenue (ttm)
142.12M
Revenue Growth
+76.27%
P/S Ratio
100.21
Revenue / Employee
1,799,025
Employees
79
Market Cap
14.24B AUD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 124.90M | 31.44M | 33.64% |
Jun 30, 2022 | 93.46M | 25.58M | 37.68% |
Jun 30, 2021 | 67.88M | 11.06M | 19.47% |
Jun 30, 2020 | 56.82M | 6.72M | 13.40% |
Jun 30, 2019 | 50.11M | 16.23M | 47.92% |
Jun 30, 2018 | 33.87M | 2.28M | 7.20% |
Jun 30, 2017 | 31.60M | 4.08M | 14.81% |
Jun 30, 2016 | 27.52M | 10.03M | 57.35% |
Jun 30, 2015 | 17.49M | 3.22M | 22.58% |
Jun 30, 2014 | 14.27M | 3.11M | 27.92% |
Jun 30, 2013 | 11.15M | -159.00K | -1.41% |
Jun 30, 2012 | 11.31M | -2.66M | -19.01% |
Jun 30, 2011 | 13.97M | -5.23M | -27.23% |
Jun 30, 2010 | 19.20M | 9.26M | 93.13% |
Jun 30, 2009 | 9.94M | 783.00K | 8.55% |
Jun 30, 2008 | 9.16M | -3.38M | -26.97% |
Jun 30, 2007 | 12.54M | 1.24M | 10.98% |
Jun 30, 2006 | 11.30M | 1.02M | 9.95% |
Jun 30, 2005 | 10.28M | 2.38M | 30.08% |
Jun 30, 2004 | 7.90M | -1.20M | -13.19% |
Jun 30, 2003 | 9.10M | -1.06M | -10.40% |
Jun 30, 2002 | 10.16M | 169.00K | 1.69% |
Jun 30, 2001 | 9.99M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 31.80B |
ResMed Inc. | 6.65B |
Cochlear Limited | 2.18B |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Sonic Healthcare Limited | 8.21B |
Ramsay Health Care Limited | 15.96B |
Telix Pharmaceuticals Limited | 502.55M |
Neuren Pharmaceuticals Limited | 231.93M |
Pro Medicus News
- 5 days ago - The five best-performing ASX 200 stocks this financial year - The Australian Financial Review
- 4 weeks ago - The ASX business so good ‘you can’t put a sell on it’ - The Australian Financial Review
- 2 months ago - Why Paradice is backing Seven Group’s bid for Boral - The Australian Financial Review
- 4 months ago - ASX PME: - The Australian Financial Review
- 4 months ago - Pro Medicus reports 1H results - Seeking Alpha
- 5 months ago - The Aussies hoping to make a fortune from Apple’s Vision Pro - The Australian Financial Review
- 8 months ago - Pro Medicus founders in $176m selldown; Unified Capital nabs trade - The Australian Financial Review